Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.

Ehrlichman RS, Gandal MJ, Maxwell CR, Lazarewicz MT, Finkel LH, Contreras D, Turetsky BI, Siegel SJ.

Neuroscience. 2009 Jan 23;158(2):705-12. doi: 10.1016/j.neuroscience.2008.10.031. Epub 2008 Oct 28.

PMID:
19015010
[PubMed - indexed for MEDLINE]
2.

NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia.

Saunders JA, Gandal MJ, Siegel SJ.

Neurobiol Dis. 2012 Apr;46(1):93-100. doi: 10.1016/j.nbd.2011.12.049. Epub 2012 Jan 9.

PMID:
22245663
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs.

Olszewski M, Piasecka J, Goda SA, Kasicki S, Hunt MJ.

Int J Neuropsychopharmacol. 2013 Jun;16(5):1009-20. doi: 10.1017/S1461145712001034. Epub 2012 Nov 21.

PMID:
23171738
[PubMed - indexed for MEDLINE]
4.

Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients.

Maxwell CR, Liang Y, Kelly MP, Kanes SJ, Abel T, Siegel SJ.

Neuroscience. 2006 Sep 1;141(3):1257-64. Epub 2006 Jun 5.

PMID:
16750890
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Hong LE, Summerfelt A, Buchanan RW, O'Donnell P, Thaker GK, Weiler MA, Lahti AC.

Neuropsychopharmacology. 2010 Feb;35(3):632-40. doi: 10.1038/npp.2009.168. Epub 2009 Nov 4.

PMID:
19890262
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.

Jones NC, Reddy M, Anderson P, Salzberg MR, O'Brien TJ, Pinault D.

Int J Neuropsychopharmacol. 2012 Jun;15(5):657-68. doi: 10.1017/S1461145711000848. Epub 2011 Jun 9.

PMID:
21733235
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.

Ehrlichman RS, Maxwell CR, Majumdar S, Siegel SJ.

J Cogn Neurosci. 2008 Aug;20(8):1403-14. doi: 10.1162/jocn.2008.20097.

PMID:
18303985
[PubMed - indexed for MEDLINE]
8.

Ketamine modulates theta and gamma oscillations.

Lazarewicz MT, Ehrlichman RS, Maxwell CR, Gandal MJ, Finkel LH, Siegel SJ.

J Cogn Neurosci. 2010 Jul;22(7):1452-64. doi: 10.1162/jocn.2009.21305.

PMID:
19583475
[PubMed - indexed for MEDLINE]
9.

Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.

Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y.

Neuroscience. 2005;133(3):729-38.

PMID:
15908134
[PubMed - indexed for MEDLINE]
10.

Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation.

Vohs JL, Chambers RA, O'Donnell BF, Krishnan GP, Morzorati SL.

Int J Psychophysiol. 2012 Nov;86(2):136-42. doi: 10.1016/j.ijpsycho.2012.04.002. Epub 2012 Apr 12.

PMID:
22504207
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.

Olszewski RT, Janczura KJ, Ball SR, Madore JC, Lavin KM, Lee JC, Lee MJ, Der EK, Hark TJ, Farago PR, Profaci CP, Bzdega T, Neale JH.

Transl Psychiatry. 2012 Jul 31;2:e145. doi: 10.1038/tp.2012.68.

PMID:
22850437
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders.

Saunders JA, Gandal MJ, Roberts TP, Siegel SJ.

Behav Brain Res. 2012 Oct 1;234(2):233-7. doi: 10.1016/j.bbr.2012.06.032. Epub 2012 Jul 5.

PMID:
22771812
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia.

McNally JM, McCarley RW, McKenna JT, Yanagawa Y, Brown RE.

Neuroscience. 2011 Dec 29;199:51-63. doi: 10.1016/j.neuroscience.2011.10.015. Epub 2011 Oct 19.

PMID:
22027237
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.

Chatterjee M, Ganguly S, Srivastava M, Palit G.

Behav Brain Res. 2011 Jan 1;216(1):247-54. doi: 10.1016/j.bbr.2010.08.001. Epub 2010 Aug 8.

PMID:
20699106
[PubMed - indexed for MEDLINE]
15.

Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression.

Featherstone RE, M Tatard-Leitman V, Suh JD, Lin R, Lucki I, Siegel SJ.

Psychopharmacology (Berl). 2013 Jun;227(4):639-49. doi: 10.1007/s00213-013-2997-9. Epub 2013 Feb 8.

PMID:
23392353
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.

Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS.

Int J Neuropsychopharmacol. 2009 Jul;12(6):823-32. doi: 10.1017/S1461145708009814. Epub 2009 Jan 21.

PMID:
19154656
[PubMed - indexed for MEDLINE]
17.

The auditory steady-state response (ASSR): a translational biomarker for schizophrenia.

O'Donnell BF, Vohs JL, Krishnan GP, Rass O, Hetrick WP, Morzorati SL.

Suppl Clin Neurophysiol. 2013;62:101-12. Review.

PMID:
24053034
[PubMed - indexed for MEDLINE]
18.

(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.

Cilia J, Hatcher P, Reavill C, Jones DN.

J Psychopharmacol. 2007 May;21(3):302-11.

PMID:
17591657
[PubMed - indexed for MEDLINE]
19.

Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.

Kittelberger K, Hur EE, Sazegar S, Keshavan V, Kocsis B.

Brain Struct Funct. 2012 Apr;217(2):395-409. doi: 10.1007/s00429-011-0351-8. Epub 2011 Oct 7.

PMID:
21979451
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice.

Featherstone RE, Liang Y, Saunders JA, Tatard-Leitman VM, Ehrlichman RS, Siegel SJ.

Neurobiol Dis. 2012 Sep;47(3):338-46. doi: 10.1016/j.nbd.2012.05.003. Epub 2012 May 22.

PMID:
22627142
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk